A Promising Link-up between the Medical Faculty, the University Hospital Center and the Private Sector.
Announcing the Creation of R/D CHUS inc.
Sherbrooke, le 2 mars 1995 – The creation of the R/D CHUS in Sherbrooke represents a promising link-up between Université de Sherbrooke's faculty of medicine, the Centre hospitalier universitaire de Sherbrooke (CHUS), and the private sector.
The goal of the newly formed enterprise is to offer researchers from around the world a favorable environment within which to develop medical and surgical instruments. R/D CHUS will also allow its staff and other participants to test, fine-tune and introduce newly invented medical instruments. "We offer inventors a chance to test their prototypes in a controlled hospital environment. They can then make their product and introduce it to the marketplace on their own or leave it to us to do it for them", says Fernand Jalbert, Manager of R/D CHUS, himself an inventor.
The need for R/D CHUS was evident with the first invention of the researchers under the supervision of Fernand Jalbert. The Laparette, a high precision instrument used in laparoscopic surgery integrates three operating functions : cauterisation, tissue irrigation and suction of residual liquids. These characteristics make it possible to carry out electrosurgery with greater autonomy and flexibility. The instrument can be used for dissection, tissue cauterisation and coagulation; the cauterisation process can also be performed at the same time as the suction or irrigation process. This development of the Laparette by Fernand Jalbert was a direct response to the need expressed by Jacques Poisson, Director of the Department of Surgery.
The bidirectional valve which distinguishes the Laparette was invented by Fernand Jalbert. At the end of the operating procedure the electrode-cannula, casing and ergonomic control handle may be washed and sterilized while only the valve is discarded. This represents an important cost savings of fifty percent (50 %) over the non-integrated instruments presently available. Furthermore, because they are not designed to be polyvalent, several of their components must be discarded after one single surgical procedure.
R/D CHUS fine-tuned the Laparette in partnership with YAB Revo-Tech. In fact the instrument is now made and marketed by YAB Revo-Tech which rents space at the CHUS to assemble its components. Cascades-Dismed handles Canadian distribution of the instrument. In the short term, YAB Revo-Tech expects to profit from the exceptional possibilities offered by the CHUS's Biomedical Park and plans to construct a laboratory for assembly. Together, R/D CHUS and Yab-Revo-Tech anticipate creating some 40 jobs if the project responds to the aspirations of its promotors.
R/D CHUS has also developed another instrument resembling the Laparette, now in the prototype stage, which will be used in gynecological surgery. Guy Waddell, a gynecologist at the CHUS and Germain Béland, Technical Coordinator at R/D CHUS have brought this to the point where working prototypes will be ready for manufacture shortly.
Today, R/D CHUS has two other inventions at the prototype stage, a patent application and various other projects currently being tested. R/D CHUS will receive royalties for these inventions which will be used to defray the costs of development and reward intellectual property rights of the inventors. The profits will be ploughed back to finance other such projects. R/D CHUS is held by the CHUS Foundation, the Faculty of Medicine of Université de Sherbrooke, and the inventors Fernand Jalbert and Germain Béland.
The Chairman of R/D CHUS is Michel Bureau, Dean of the Faculty of Medicine. "Our company will make it possible to develop the best surgical instruments, to create jobs thanks to the capital pool in the Eastern Townships, and to return to Quebec society a part of the money it has invested in our university," states Dean Bureau.
Research and development which will be carried out at R/D CHUS will also drive several other projects which are planned in the Biomedical Park and which will offer many possibilities for student research in several faculties. Sherbrooke Rector, Pierre Reid is delighted with this partnership arrangement. "It fits in with the University's orientation to promote the commercial transfer and use of technology developed by our researchers and partners, like the CHUS. As well as promoting the quality of our research, it will also encourage collaboration with dynamic businesses and contribute to the growth of the Quebec economy."
– 30 –
Source : Gilles Pelloille, Head of Communications
Renseignements : Fernand Jalbert, Manager, R/D CHUS
(819) 563-5555 (loc. 4440)